Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Sets the GUINNESS WORLD RECORDS™ Title for the Largest Business Partnering Event
June 6, 2018
Washington, DC (June 6, 2018) – This morning at the Biotechnology Innovation Organization’s (BIO) International Convention in Boston, BIO proudly attempted – and set– the GUINNESS WORLD RECORDS title for the Largest Business Partnering Event.
South Dakota Governor Dennis Daugaard Presented BIO Lifetime Champion Award
June 6, 2018
Boston, MA (June 6, 2018) –  The Biotechnology Innovation Organization (BIO) presented South Dakota Governor Dennis Daugaard with a Lifetime Champion Award in recognition of his stalwart leadership and commitment to strengthening…
BIO Presents the Henri A. Termeer Biotechnology Visionary Award to Gates Foundation’s Dr. Sue Desmond-Hellmann
June 6, 2018
Washington, D.C. (June 6, 2018) – The Biotechnology Innovation Organization (BIO) is pleased to announce the establishment of the Henri A. Termeer Biotechnology Visionary Award – created in honor of the late Genzyme CEO who was…
Massachusetts Governor Charlie Baker Presented 2018 BIO Governor of the Year Award
June 5, 2018
Boston, MA (June 5, 2018) –  The Biotechnology Innovation Organization (BIO) today presented Massachusetts Governor Charlie Baker with its 2018 Governor of the Year award in recognition of his leadership and commitment to…
BIO Elects New Board Directors and Section Governing Board Chairs
June 5, 2018
Boston, MA (June 5, 2018) – The Biotechnology Innovation Organization (BIO) is pleased to announce the election of 11 new board directors and several new section governing board chairs and vice chairs at the 2018 BIO International…
National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth
June 5, 2018
A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S…
New Bioscience Report Shows Record-Breaking Economic Impact, Accelerated Venture Capital Investment & Job Growth
June 4, 2018
BIO’s latest report shows that the U.S. bioscience industry has reached record setting annual economic impact, venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry is a leading economic driver and…
New Report Shows Substantial Economic Costs of Chinese Delays on Ag-Biotech Approvals
May 30, 2018
Washington, D.C. (May 30, 2018) – Persistent delays in China’s ag-biotech regulatory system slows U.S. farmers’ access to new biotechnology products and costs the U.S. economy tens of thousands of jobs and billions in economic output, according to a…
BIO Announces Renewable Chemicals Programming for 2018 World Congress
May 25, 2018
The Biotechnology Innovation Organization (BIO) today announced programming information for renewable chemicals at the 2018 BIO World Congress on Industrial Biotechnology. Programming will consist of four breakout sessions on Tuesday, July 17,…
Biotech Leader Testifies Before House Capital Markets Subcommittee
May 23, 2018
Washington, DC (May 23, 2018) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House of Representatives Committee on Financial…